Browsing by Subject
Ara mostrant els elements 1-20 d 122
-
30-Day Mortality Following Palliative Radiotherapy
(Frontiers Media, 2021-04-23) -
A framework for artificial intelligence in cancer research and precision oncology
(Nature Portfolio, 2023-05-17) -
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors
(Oxford University Press, 2024-01) -
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
(American Association for Cancer Research, 2022-06-01) -
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
(American Association for Cancer Research, 2023-01-17) -
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
(Nature Portfolio, 2024-02-21) -
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
(Nature Research, 2021-02-23) -
An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry
(American Society of Clinical Oncology, 2022-08-08) -
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial
(American Medical Association, 2023-11) -
AXL – a new player in resistance to HER2 blockade
(Elsevier, 2023-12)